--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--------
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 22.990
- +0.800+3.61%
Trading Nov 21 13:22 ET
840.89MMarket Cap-11705P/E (TTM)
23.442High21.885Low36.13KVolume22.330Open22.190Pre Close808.51KTurnover0.39%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High2.60P/B211.51MFloat Cap16.55052wk Low--Dividend TTM9.20MShs Float29.740Historical High--Div YieldTTM7.02%Amplitude16.550Historical Low22.377Avg Price1Lot Size
Rapport Therapeutics Key Stats
Rapport Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Rapport Therapeutics Earnings Reports
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
